SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:lup.lub.lu.se:7e5ad58d-dc98-4497-98bf-501fb0a766c5"
 

Sökning: onr:"swepub:oai:lup.lub.lu.se:7e5ad58d-dc98-4497-98bf-501fb0a766c5" > Sodium-glucose co-t...

  • Pandey, Arjun K.McMaster University (författare)

Sodium-glucose co-transporter inhibitors and atrial fibrillation : A systematic review and meta-analysis of randomized controlled trials

  • Artikel/kapitelEngelska2021

Förlag, utgivningsår, omfång ...

  • 2021

Nummerbeteckningar

  • LIBRIS-ID:oai:lup.lub.lu.se:7e5ad58d-dc98-4497-98bf-501fb0a766c5
  • https://lup.lub.lu.se/record/7e5ad58d-dc98-4497-98bf-501fb0a766c5URI
  • https://doi.org/10.1161/JAHA.121.022222DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:art swepub-publicationtype
  • Ämneskategori:ref swepub-contenttype

Anmärkningar

  • BACKGROUND: Sodium-glucose co-transporter (SGLT) inhibitors reduce cardiovascular outcomes including mortality in several populations; however, their effect on atrial fibrillation/flutter (AF) remains unclear. Our objective was to determine whether SGLT inhibitors reduce AF and whether a history of AF modifies the effect of SGLT inhibitors on the composite of heart failure hospitalization or cardiovascular death. METHODS AND RESULTS: We searched MEDLINE, Embase, and CENTRAL to March 2021. Pairs of reviewers identified randomized controlled trials that compared an SGLT inhibitor with placebo or no therapy. We pooled data using RevMan 5.4.1, assessed risk of bias using the Cochrane tool, and determined the overall quality of evidence using Grades of Recommendation, Assessment, Development and Evaluation. Thirty-one eligible trials reported on AF events (75 279 participants, mean age 62 years, 35.0% women). Moderate quality evidence supported a lower risk of serious AF events with SGLT inhibitors (1.1% versus 1.5%; risk ratio 0.75 [95% CI, 0.66–0.86]; I2=0%). A similar reduction in total AF events was also noted with SGLT inhibitors. Three trials reported on heart failure hospitalization/cardiovascular death stratified by a baseline history of AF (18 832 participants, mean age 66 years, 38.1% women); in patients with a history of AF, SGLT inhibitors resulted in a lower risk in the composite of heart failure hospitalization or cardiovascular death (hazard ratio, 0.70 [95% CI, 0.57–0.85]; I2=0%)—similar to the effect estimate for patients without AF, P value for interaction: 1.00. CONCLUSIONS: SGLT inhibitors may reduce AF events and likely reduce heart failure hospitalization/cardiovascular death to a similar extent in patients with and without AF.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Okaj, IvaMcMaster University (författare)
  • Kaur, HargunMcMaster University (författare)
  • Belley-Cote, Emilie P.Population Health Research Institute, Ontario,McMaster University (författare)
  • Wang, Jia-xiangPopulation Health Research Institute, Ontario (författare)
  • Oraii, AlirezaUniversity of Tehran (författare)
  • Benz, Alexander P.Population Health Research Institute, Ontario (författare)
  • Johnson, Linda S.B.Lund University,Lunds universitet,Kardiovaskulär forskning - epidemiologi,Forskargrupper vid Lunds universitet,Cardiovascular Research - Epidemiology,Lund University Research Groups(Swepub:lu)med-laj (författare)
  • Young, JackMcMaster University (författare)
  • Wong, Jorge A.McMaster University,Population Health Research Institute, Ontario (författare)
  • Verma, SubodhSaint Michael's Hospital (författare)
  • Conen, DavidPopulation Health Research Institute, Ontario,McMaster University (författare)
  • Gerstein, HertzelPopulation Health Research Institute, Ontario,McMaster University (författare)
  • Healey, Jeff S.McMaster University (författare)
  • McIntyre, William F.Population Health Research Institute, Ontario,McMaster University (författare)
  • McMaster UniversityPopulation Health Research Institute, Ontario (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Journal of the American Heart Association10:172047-9980

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy